Breaking News

Over a month ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Conference/Events
Poxel management to meet virtually with JMP Securities » 04:55
10/07/22
10/07
04:55
10/07/22
04:55
PXXLF

Poxel

$2.60 /

+ (+0.00%)

Virtual Meetings to be…

Virtual Meetings to be held on October 3-7 hosted by JMP Securities.

ShowHide Related Items >><<
PXXLF Poxel
$2.60 /

+ (+0.00%)

Conference/Events
Poxel management to meet virtually with JMP Securities » 05:55
10/06/22
10/06
05:55
10/06/22
05:55
PXXLF

Poxel

$2.60 /

+ (+0.00%)

Virtual Meetings to be…

Virtual Meetings to be held on October 3-7 hosted by JMP Securities.

ShowHide Related Items >><<
PXXLF Poxel
$2.60 /

+ (+0.00%)

Conference/Events
Poxel management to meet virtually with JMP Securities » 04:55
10/05/22
10/05
04:55
10/05/22
04:55
PXXLF

Poxel

$2.60 /

+ (+0.00%)

Virtual Meetings to be…

Virtual Meetings to be held on October 3-7 hosted by JMP Securities.

ShowHide Related Items >><<
PXXLF Poxel
$2.60 /

+ (+0.00%)

Conference/Events
Poxel management to meet virtually with JMP Securities » 04:55
10/04/22
10/04
04:55
10/04/22
04:55
PXXLF

Poxel

$2.60 /

+ (+0.00%)

Virtual Meetings to be…

Virtual Meetings to be held on October 3-7 hosted by JMP Securities.

ShowHide Related Items >><<
PXXLF Poxel
$2.60 /

+ (+0.00%)

Conference/Events
Poxel management to meet virtually with JMP Securities » 04:55
10/03/22
10/03
04:55
10/03/22
04:55
PXXLF

Poxel

$2.60 /

+ (+0.00%)

Virtual Meetings to be…

Virtual Meetings to be held on October 3-7 hosted by JMP Securities.

ShowHide Related Items >><<
PXXLF Poxel
$2.60 /

+ (+0.00%)

Conference/Events
Poxel management to meet virtually with JMP Securities » 13:33
09/27/22
09/27
13:33
09/27/22
13:33
PXXLF

Poxel

$2.60 /

+ (+0.00%)

Virtual Meetings to be…

Virtual Meetings to be held on October 3-7 hosted by JMP Securities.

ShowHide Related Items >><<
PXXLF Poxel
$2.60 /

+ (+0.00%)

Hot Stocks
Poxel Autosomal Dominant Polycystic Kidney Disease treatment gets orphan status » 12:01
09/14/22
09/14
12:01
09/14/22
12:01
PXXLF

Poxel

$2.60 /

+ (+0.00%)

A potential treatment of…

A potential treatment of Autosomal Dominant Polycystic Kidney Disease being developed by Poxel S.A. has been granted FDA orphan designation, according to a post to the agency website. Reference Link

ShowHide Related Items >><<
PXXLF Poxel
$2.60 /

+ (+0.00%)

Over a quarter ago
Hot Stocks
Poxel treatment of X-Linked Adrenoleukodystrophy granted orphan status » 14:58
05/12/22
05/12
14:58
05/12/22
14:58
PXXLF

Poxel

$2.10 /

+ (+0.00%)

A treatment of X-Linked…

A treatment of X-Linked Adrenoleukodystrophy being developed by Poxel S.A. was granted orphan designation by the FDA, according to a post to the agency's website. Reference Link

ShowHide Related Items >><<
PXXLF Poxel
$2.10 /

+ (+0.00%)

Hot Stocks
Poxel treatment of X-Linked Adrenoleukodystrophy granted orphan status » 11:56
04/11/22
04/11
11:56
04/11/22
11:56
PXXLF

Poxel

$2.58 /

+ (+0.00%)

Poxel's treatment of…

Poxel's treatment of X-Linked Adrenoleukodystrophy was granted orphan status by the FDA, according to a post to the agency's website. Reference Link

ShowHide Related Items >><<
PXXLF Poxel
$2.58 /

+ (+0.00%)

Hot Stocks
Poxel reports revenues of EUR 13.4M for year ended December 31, 2021 » 11:48
02/16/22
02/16
11:48
02/16/22
11:48
PXXLF

Poxel

$5.83 /

+ (+0.00%)

As of December 31, 2021,…

As of December 31, 2021, cash and cash equivalents were EUR 32.3M, or $36.6M, the company said. "2021 has been another productive year for Poxel. We supported our partner Sumitomo Dainippon Pharma, a leading company in the diabetes field in Japan, across all steps that led to the Japanese approval of TWYMEEG in June followed by its launch in September. Sumitomo has a track record of success and we look forward to their further activities in Japan and other territories to maximize TWYMEEG's commercial performance," said Thomas Kuhn, CEO of Poxel.

ShowHide Related Items >><<
PXXLF Poxel
$5.83 /

+ (+0.00%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.